Suppr超能文献

评估一种含有益生元、益生菌和后生元的新型化合物在健康猫和狗中的安全性和功能。

Evaluating the safety and functionality of a novel compound containing prebiotics, probiotics, and postbiotics in healthy cats and dogs.

作者信息

Onuma Mamoru, Ataka Kai, Murakami Akiyoshi

机构信息

Oosagami Animal Clinic, Koshigaya-shi, Japan.

Department of Animal Risk Management, Faculty of Risk and Crisis Management, Chiba Institute of Science, Choshi, Japan.

出版信息

Open Vet J. 2025 May;15(5):1969-1981. doi: 10.5455/OVJ.2025.v15.i5.11. Epub 2025 May 31.

Abstract

BACKGROUND

Although various prebiotics, probiotics, and postbiotics are available, their safety and efficacy in combination are unknown.

AIM

We investigated the safety and functionality of a newly developed supplement, previously unreported in pet animals, containing 26 types of biotic material bacteria (2 prebiotics, 1 probiotic, and 23 postbiotics) in cats and dogs. The biotic materials included were selected based on current evidence from cats and dogs.

METHODS

A new supplement developed using species tested in cats and dogs was administered. One-way analysis was used for data obtained from 3 cats (7 days of treatment and 7 days of nontreatment), and a parallel, controlled study was performed in 20 dogs ( = 10 each in control and test groups, for 27 days).

RESULTS

In cats, no abnormal values were observed in complete blood count or blood chemistry tests, whereas significant decreases in blood glucose and total cholesterol were confirmed ( < 0.05 each). In the feline lymphocyte subset test, significant increases were observed in T and B cells ( < 0.05). A significant difference in fecal pH was observed in the test group ( < 0.01). In addition, 60% (9/15) of the test group had an increase in total organic acids. In dogs, only indole showed a consistent decrease among putrefactive products ( = 0.055). Regarding analyses of intestinal flora from feces using a gene sequencer at the genus level, no changes were observed in cats. Conversely, and genera tended to be decreased in the control group but increased by 23.1% and 45%, respectively, in the test group. In addition, and genera showed slight increases or changes in the control group but significant decreases in the test group. Regarding the ratio, an increase in the control group and a decrease in the test group were observed in all cats, whereas no differences were observed in dogs.

CONCLUSION

The supplement is safe for both cats and dogs. Results of comprehensive analyses suggested that the supplement improved the intestinal environment by regulating the gastrointestinal microbiota.

摘要

背景

尽管有各种益生元、益生菌和后生元,但它们联合使用时的安全性和功效尚不清楚。

目的

我们研究了一种新开发的补充剂在猫和狗中的安全性和功能,该补充剂含有26种生物材料细菌(2种益生元、1种益生菌和23种后生元),此前在宠物中未被报道。所包含的生物材料是根据猫和狗的现有证据选择的。

方法

给予一种使用在猫和狗身上测试过的物种开发的新补充剂。对从3只猫获得的数据(治疗7天和非治疗7天)进行单向分析,并在20只狗中进行平行对照研究(对照组和试验组各10只,为期27天)。

结果

在猫中,全血细胞计数或血液化学测试未观察到异常值,而血糖和总胆固醇显著降低(均P<0.05)。在猫淋巴细胞亚群测试中,T细胞和B细胞显著增加(P<0.05)。试验组粪便pH值有显著差异(P<0.01)。此外,试验组60%(9/15)的总有机酸增加。在狗中,只有吲哚在腐败产物中呈持续下降(P=0.055)。关于使用基因测序仪在属水平对粪便肠道菌群进行的分析,猫未观察到变化。相反,对照组中拟杆菌属和梭菌属趋于减少,但试验组中分别增加了23.1%和45%。此外,双歧杆菌属和乳酸杆菌属在对照组中略有增加或变化,但在试验组中显著减少。关于拟杆菌属与厚壁菌属的比例,所有猫的对照组增加而试验组减少,而狗未观察到差异。

结论

该补充剂对猫和狗均安全。综合分析结果表明,该补充剂通过调节胃肠道微生物群改善了肠道环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467e/12184448/e749bfa78c8a/OpenVetJ-15-1969-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验